Johanna Paola Contreras, M.D, MSC
NPI 1528188190ActiveIndividual· Internal Medicine, Advanced Heart Failure and Transplant Cardiology· New York, NY
Internal Medicine, Advanced Heart Failure and Transplant Cardiology (M.D, MSC) with Icahn School of Medicine at Mount Sinai, practicing in New York, New York. Their prescriptions cost Medicare Part D more than their services did: $4,003,064 for 3,474 claims, against $51,427 paid for services in 2024. Bridgebio Pharma, Inc. was the largest of 23 companies reporting payments in 2025, $32,381 in all, mostly consulting fees. Lists Mount Sinai Beth Israel and 2 other hospitals as hospital affiliations.
Overview
| NPI | 1528188190 |
|---|---|
| Status | Active |
| Entity type | Individual |
| Credential | M.D, MSC |
| Sole proprietor | Yes |
| NPI issued | Mar 29, 2007 |
| Last updated in NPPES | Oct 12, 2023 |
| Certified by provider | Oct 12, 2023 |
Specialties and licenses
| Taxonomy | Code | License | State |
|---|---|---|---|
| Internal Medicine, Advanced Heart Failure and Transplant Cardiology Primary | 207RA0001X | 263133 | NY |
| Internal Medicine, Cardiovascular Disease | 207RC0000X | 263133 | NY |
Exclusion screening
| List | Result | Details |
|---|---|---|
| HHS-OIG LEIE · Oct 9, 2026 | No match | Checked by NPI and by name + state |
| North Carolina Medicaid · Nov 10, 2026 | No match | — |
| New York OMIG · Nov 10, 2026 | No match | — |
| Ohio Medicaid · Nov 10, 2026 | No match | — |
| Pennsylvania Medicheck · Nov 10, 2026 | No match | — |
| Washington HCA · Nov 10, 2026 | No match | — |
Official OIG search · How matching works ·Bulk check a roster
Medicare
| Enrollment (PECOS) | Enrolled Practitioner - Advanced Heart Failure and Transplant Cardiology (NY) |
|---|---|
| Accepts assignment | Yes (participating) |
Medicare services in 2024
| Medicare patients | 158 |
|---|---|
| Services billed | 540 across 15 procedure codes |
| Paid by Medicare | $51,427 |
Part D prescriptions in 2024
| Prescriptions (claims) | 3,474 · 6,086 30-day fills |
|---|---|
| Patients | 297 |
| Total drug cost | $4,003,064 |
| Generic share | 61% of claims |
Education and affiliations
| Graduation year | 1998 |
|---|---|
| Medicare specialty | Advanced Heart Failure And Transplant Cardiology |
| Secondary specialties | Cardiovascular Disease (Cardiology) |
Medical group
- Icahn School of Medicine at Mount SinaiNew York, NY · 2,843 clinicians
Hospital affiliations
- Mount Sinai Beth IsraelNew York, NY
- Mount Sinai HospitalNew York, NY
- Mount Sinai WestNew York, NY
Industry payments (Open Payments)
- 2025$32,381 · 163 payments from 23 companies
- 2024$109,866 · 213 payments from 24 companies
Top paying companies in 2025
| Company | Amount | Payments |
|---|---|---|
| Bridgebio Pharma, Inc. | $12,288 | 35 |
| Bayer Healthcare Pharmaceuticals Inc. | $10,643 | 16 |
| Alnylam Pharmaceuticals Inc. | $4,768 | 12 |
| Merck Sharp & Dohme LLC | $1,373 | 9 |
| Astrazeneca Pharmaceuticals LP | $684.20 | 22 |
What the 2025 payments were for
- Consulting Fee$17,090 · 3 payments
- Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program$9,048 · 3 payments
- Food and Beverage$5,151 · 153 payments
- Travel and Lodging$1,093 · 4 payments
Receiving payments does not imply wrongdoing. What Open Payments covers ·original records
Other Internal Medicine, Advanced Heart Failure and Transplant Cardiology providers in New York
- 1124333182
- 1568717692
- 1740561133
- 1841459997
- 1053706325
- 1063918456
- 1225115082
- 1356604607
- 1376905380
- 1649563073
- 1336226810
- 1073994208
All Internal Medicine, Advanced Heart Failure and Transplant Cardiology providers in New York →